Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6378-6383

  Tillman, Bryan W ^a   De Gruijl, Tanja D ^b   Luykx de Bakker, Sylvia A ^b   Scheper, Rik J ^b   Pinedo, Herbert M ^b   Curiel, Tyler J ^c   Gerritsen, Winald R ^b   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL MATURATION; DENDRITIC CELL; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOSTIMULATION; PHENOTYPE; PRIORITY JOURNAL;

ADENOVIRUSES, HUMAN; ANTIGENS, CD40; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROVIRUS; EPITOPES; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; IMMUNOPHENOTYPING; MONOCYTES; RECEPTORS, VIRUS;

EID: 0033152688     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
3. + T-helper and a T-killer cell. Nature 393: 474.
4. Clark, E. A. 1997. Regulation of B-lymphocytes by dendritic cells. J. Exp. Med. 185:801.
5. Manickan, E., S. Kanangat, R. J. D. Rouse, Z. Yu, and B. T. Rouse. 1997. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukocyte Biol. 61:125.
6. Tuting, T., A. B. DeLeo, M. T. Lotze, and W. J. Storkus. 1997. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo. Eur. J. Immunol. 27:2702.
7. Reeves, M. E., R. E. Royal, J. S. Lam, S. A. Rosenberg, and P. Hwu. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:5672.
8. Lotze, M. T., H. Farhood, C. C. Wilson, and W. J. Storkus. 1999. Dendritic cell therapy of cancer and HIV infection. In Dendritic Cells: Biology and Clinical Applications. M. T. Lotze, and A. W. Thomson, eds. Academic Press, San Diego.
9. Arthur, J. F., L. H. Butterfleld, M. D. Roth, L. A. Bui, S. M. Kiertscher, R. Lau, S. Dubinett, J. Glaspy, W. H. McBride, and J. S. Economou. 1997. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4:17.
10. Van Tendeloo, V. F. I., H. W. Snoeck, F. Lardon, G. L. E. E. Vanham, G. Nijs, M. Lenjou, L. Hendriks, C. Van Broeckhoven, A. Moulijn, I. Rodrigus, et al. 1998. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoetic progenitor-but not monocyte-derived dendritic cells. Gene Ther. 5:700.
11. Dietz, A. B., and S. Vuk-Pavlovic. 1998. High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 91:392.
12. Tuting, T., L. Zitvogel, and Y. Nishioka. 1999. Genetic engineering of dendritic cells. In Dendritic Cells: Biology and Clinical Applications. M. T. Lotze, and A. W. Thomson, eds. Academic Press, San Diego, p. 607.
13. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320.
14. Li, E., D. Stupack, R. Klemke, D. A. Cheresh, and G. R. Nemerow. 1998. Adenovirus endocytosis via α(v) integrins requires phosphoinositide-3-OH kinase. J. Virol. 72:2055.
15. 5 promote adenovirus internalization but not virus attachment. Cell 73:309.
16. Goldman, C. K., B. E. Rogers, J. T. Douglas, B. A. Sosnowski, W. Ying, G. P. Siegal, A. Baird, J. A. Campain, and D. T. Curiel. 1997. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57:1447.
17. Douglas, J. T., B. E. Rogers, M. E. Rosenfeld, S. I. Michael, M. Feng, and D. T. Curiel. 1996. Targeted gene delivery by tropism modified adenoviral vectors. Nature Biotechnol. 14:1574.
18. Wickham, T. J., D. M. Segal, P. W. Roelvink, M. E. Carrion, A. Lizonova, G. M. Lee, and I. Kovesdi. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:6831.
19. Makino, M., and M. Baba. 1997. A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand. J. Immunol. 45:618.
20. Segal, D. M., and B. J. E. G. Bast. 1994. Production of bispecific antibodies. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. M. Kruisbeek, D. A. Marguiles, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 2.13.1.
21. van der Pouw Kraan, T. C., L. C. Boeije, E. R. de Groot, S. O. Stapel, A. Snijders, M. L. Kapsenberg, J. S. van der Zee, and L. A. Aarden. 1997. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J. Immunol. 158:5560.
22. Miller, C. R., D. J. Buchsbaum, P. N. Reynolds, J. T. Douglas, G. Y. Gillespie, M. S. Mayo, D. Raben, and D. T. Curiel. 1998. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 58:5738.
23. Schulick, A. H., K. D. Newman, R. Virmani, and D. A. Dichek. 1995. In vivo gene transfer into injured carotid arteries. Circulation 91:2407.
24. Ledbetter, J. A., L. S. Grosmaire, D. Hollenbach, A. Aruffo, and S. G. Nadler. 1995. Agonistic and antagonistic properties of CD40 mAb G28-5 are dependent on binding valency. Circ. Shock 44:67.
25. Bennett, S. R. M., F. Carbone, F. Karamalis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478.
26. Schoenberger, S. P., R. E. M. Toes, E. I. H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cylotoxic T-lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
27. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Legation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
28. Van Schooten, W. C. A., G. Strang, and V. Palathumpat. 1997. Biological properties of dendritic cells: implications to their use in the treatment of cancer. Mol. Med. Today 3:254.
29. Guerder, S., and P. Matzinger. 1992. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 176:553.
30. Steinbrink, K., M. Wolft, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
31. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
32. Shurin, M. R., C. Esche, A. Lokshin, and M. T. Lotze. 1999. Apoptosis in dendritic cells. In Dendritic Cells: Biology and Clinical Applications. M. T. Lotze, and A. W. Thompson, eds. Academic Press, San Diego, p. 673.
33. Labeur, M. S., B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:168.
34. Peitsch, M. C., and C. V. Jongeel. 1993. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 5:233.